secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001437749-23-004092
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife appoints Janie Goddard as independent director
--------------------------------------------------------

- Janie Goddard appointed to Ultralife Board effective February 21, 2023.
- Goddard is Divisional CEO at Halma plc; previously led at Novanta, Welch Allyn, Covidien, Johnson & Johnson.
- She will serve on Audit & Finance, Compensation & Management, and Corporate Development & Governance committees.
- Goddard also serves on the board of Methode Electronics (NYSE: MEI).
- Compensation follows standard non-employee director terms per 2022 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774923004092/0001437749-23-004092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774923004092/ulbi20230221_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-004092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer